Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy

被引：27

作者：

Uger, Robert ^{[1
]}

Johnson, Lisa ^{[2
]}

机构：

[1] Trillium Therapeut Inc, 2488 Dunwin Dr, Mississaugua, ON L5L 1J9, Canada

[2] Trillium Therapeut Inc, Translat Res, Mississaugua, ON, Canada

来源：

EXPERT OPINION ON BIOLOGICAL THERAPY | 2020年 / 20卷 / 01期

关键词：

CD47; immunotherapy; lymphoma; macrophage; phagocytosis; CD47; MACROPHAGES;

D O I：

10.1080/14712598.2020.1685976

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：5 / 8

页数：4

共 19 条

[1]

Advani R, 2019, HEMATOL ONCOL, V37, P89

[2]

[Anonymous], 2019, J CLIN ONCOL S

[3] Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma [J].

Chao, Mark P. ;

Alizadeh, Ash A. ;

Tang, Chad ;

Myklebust, June H. ;

Varghese, Bindu ;

Gill, Saar ;

Jan, Max ;

Cha, Adriel C. ;

Chan, Charles K. ;

Tan, Brent T. ;

Park, Christopher Y. ;

Zhao, Feifei ;

Kohrt, Holbrook E. ;

Malumbres, Raquel ;

Briones, Javier ;

Gascoyne, Randy D. ;

Lossos, Izidore S. ;

Levy, Ronald ;

Weissman, Irving L. ;

Majeti, Ravindra .

CELL, 2010, 142 (05) :699-713

[4] A phase I study of ALX148, a CD47 blocker, in combination with established anticancer antibodies in patients with advanced malignancy. [J].

Chow, Laura Quan Man ;

Gainor, Justin F. ;

Lakhani, Nehal J. ;

Chung, Hyun Cheol ;

Lee, Keun-Wook ;

Lee, Jeeyun ;

LoRusso, Patricia ;

Bang, Yung-Jue ;

Hodi, F. Stephen ;

Fanning, Philip ;

Zhao, Yonggang ;

Jin, Feng ;

Wan, Hong ;

Pons, Jaume ;

Randolph, Sophia ;

Messersmith, Wells A. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[5]

GILES C, 1981, BRIT J HAEMATOL, V48, P31

[6] ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile [J].

Kauder, Steven E. ;

Kuo, Tracy C. ;

Harrabi, Ons ;

Chen, Amy ;

Sangalang, Emma ;

Doyle, Laura ;

Rocha, Sony S. ;

Bollini, Sangeetha ;

Han, Bora ;

Sim, Janet ;

Pons, Jaume ;

Wan, Hong, I .

PLOS ONE, 2018, 13 (08)

[7] Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines [J].

Kim, Min Jung ;

Lee, June-Chul ;

Lee, Jae-Jung ;

Kim, Soyeon ;

Lee, Sang Goo ;

Park, Seok-Woo ;

Sung, Myung Whun ;

Heo, Dae Seog .

TUMOR BIOLOGY, 2008, 29 (01) :28-34

[8] TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets [J].

Lin, Gloria H. Y. ;

Chai, Vien ;

Lee, Vivian ;

Dodge, Karen ;

Truong, Tran ;

Wong, Mark ;

Johnson, Lisa D. ;

Linderoth, Emma ;

Pang, Xinli ;

Winston, Jeff ;

Petrova, Penka S. ;

Uger, Robert A. ;

Viller, Natasja N. .

PLOS ONE, 2017, 12 (10)

[9] Inhibition of SIRP in dendritic cells potentiates potent antitumor immunity [J].

Liu, Qiong ;

Wen, Wen ;

Tang, Liang ;

Qin, Chen-Jie ;

Lin, Yan ;

Zhang, Hui-Lu ;

Wu, Han ;

Ashton, Charles ;

Wu, Hong-Ping ;

Ding, Jin ;

Dong, Wei ;

Yu, Le-Xing ;

Yang, Wen ;

Huang, Dan-Dan ;

Wu, Meng-Chao ;

Wang, Hong-Yang ;

Yan, He-Xin .

ONCOIMMUNOLOGY, 2016, 5 (09)

[10] CD47 blockade triggers T cell-mediated destruction of immunogenic tumors [J].

Liu, Xiaojuan ;

Pu, Yang ;

Cron, Kyle ;

Deng, Liufu ;

Kline, Justin ;

Frazier, William A. ;

Xu, Hairong ;

Peng, Hua ;

Fu, Yang-Xin ;

Xu, Meng Michelle .

NATURE MEDICINE, 2015, 21 (10) :1209-+

← 1 2 →